pipeline

a lot of scissors
Biotech

Evotec axes 30% of assets as cost-cutting push hits pipeline

The company axed around 30% of its asset portfolio and offloaded clinical program EVT 201 as part of a broader, ongoing attempt to correct its course.
Nick Paul Taylor Apr 17, 2025 9:45am
Whirlpool in water

Cyclacel sheds clinical asset in effort to stop cash spiral

Apr 2, 2025 6:01pm
china chinese Asia

ImmuneOnco axes CD47 bispecific amid pipeline prioritization

Mar 26, 2025 6:21am
too many options

Adaptimmune questions own longevity, axes preclinical funding

Mar 20, 2025 2:04pm
Abstract modern white spiral clock dial with roman and arabic numerals

Cell therapy biotech axes cancer trial, turns to autoimmune

Mar 19, 2025 5:35pm
pipeline pipes development workers

Zymeworks withholds one ADC from clinic in favor of another

Mar 6, 2025 10:25am